2021-2025       Project Grant, Clinical Trials and Cohort Studies, National Health & MRC, Australia.

  • Australasian Malignant Pleural Effusion (AMPLE)-3 trial

  Lee YCG, Maskell NA, Feller-Kopman D, Wright G, Murray K, Norman R, Fysh ETH, Newton R,  

  Creaney J, Windsor M. (AUD$1,105,748.65)    University of Western Australia, Perth, Australia.

 

2021-2025       Centre of Research Excellence in Clinical Research, National Health & MRC, Australia.

  • The National Centre for Asbestos Related Diseases.

Nowak A, Creaney J, Lee YCG, Lesterhuis W, Waddell N, Brims F, Francis R, Lake R, Takahashi K and Robinson BW. (AUD$2,500,000)   University of Western Australia, Perth, Australia.

 

2021-2022       Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • The Third PLeural Effusion And Symptom Evaluation (PLEASE-3) Study: Bendopnea in patients with pleural effusion

Lee YCG. (AUD$29,682)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2021                Western Australia Health Medical and Health Research Infrastructure Fund for 2020. 

Lee YCG. (AUD$65,100)                Institute for Respiratory Health, Perth, Australia.

 

2020-2021       Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia.  

  • A multicentre placebo-controlled randomized clinical trial of systemic corticosteroid for adult patients with community-acquired pneumonia and associated pleural effusion.

   Lee YCG. (AUD$29,390)   Sir Charles Gairdner Hospital, Perth, Australia.

 

2020                Project Grant, iCare Dust Diseases Care Board, Australia.

  • Psychosocial impact and needs of mesothelioma patients/carers: A neglected area.

   Breen L, Lee YCG & Peddle- McIntyre C. (AUD$ 50,525)   Curtin University, Perth, Australia.

 

2020                Western Australia Health Medical and Health Research Infrastructure Fund for 2019. 

Lee YCG. (AUD$73,680)                Institute for Respiratory Health, Perth, Australia.

 

2019-2020       Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia.  

  • The role of citrate in the pathobiology of malignant pleural mesothelioma.

   Lee YCG. (AUD$29,900)      Sir Charles Gairdner Hospital, Perth, Australia.

 

2019                Western Australia Health Medical and Health Research Infrastructure Fund for 2018. 

Lee YCG. (AUD$69,897)      Institute for Respiratory Health, Perth, Australia.

 

2018-2022       Practitioner Fellowship, Medical Research Future Fund Next Generation Clinical

   Researcher Program, National Health & Medical Research Council, Australia.

  • Translational research on malignant pleural effusion and pleural infection.

   Lee YCG.   (AUD$481,155)   University of Western Australia, Australia.

 

2018-2020       Project Grant, iCare Dust Diseases Care Board, Australia.

  • Australasian Malignant PLeural Effusion (AMPLE) trial -3.

   Lee YCG (PI), Maskell N, Feller-Kopman D, Murray K, Creaney J & Newton RU. (AUD$299,871)

   Institute for Respiratory Health, Perth, Australia.

 

2018-2019       Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Steroid Therapy and Outcome of Parapneumonic Pleural Effusion (STOPPE) trial: a pilot multi-centre placebo-controlled randomized study

Lee YCG. (AUD$40,000)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2018-2020       Project Grant, Hong Kong Lung Foundation, Hong Kong.

  • To determine the efficacy of autologous blood patch therapy in reducing air leak in secondary

    spontaneous pneumothorax: A proof-of-concept study (HKD$170,000)

   Ngai CL, Lee YCG, Ng SS, Chan KP, Hui DSC, Lam WK.

   Chinese University of Hong Kong, Hong Kong.

 

2018                Project Grant, Hong Kong Lung Foundation, Hong Kong.

  • Activity behaviors in patients with malignant pleural effusion: relationships with quality of life, and respiratory symptoms, and survival (HKD$40,000)

   Lam DCC, Lui M, Lee YCG, Chan J, Law W-L, Yeung Y-C, Ngai J.

   University of Hong Kong, Hong Kong.

 

2018                Project Grant, Cancer Council of Western Australia, Australia. 

  • Targeting MCP-1 as a novel therapy for mesothelioma and malignant pleural effusion.

   Lansley S, Creaney J, Lee YCG, Thomas R & Feindel KW.   (AUD$95,738)

   Institute for Respiratory Health, Perth, Australia.

 

2018                Western Australia Health Medical and Health Research Infrastructure Fund for 2017. 

Lee YCG. (AUD$52,388)                Institute for Respiratory Health, Perth, Australia.

 

2017-2019       Project Grant, National Health & Medical Research Council, Australia. 

  • Compartmental analysis of T-cell responses in thoracic malignancies.

   Robinson BWS, Lee YCG, Creaney J, Lake R, Holt R, Nowak A, Watson M, Pearson J & Chee J.

   (AUD$851,402)   University of Western Australia, Australia.   

 

2017                Project Support, the Cancer Research Trust Single Cancer Cell Initiative 2017. 

  • Single cell sequencing in pleural effusions of malignant mesothelioma patients

   Creaney J, Robinson BWS, Lee YCG, Muiri DO.

   National Centre for Asbestos Related Diseases, Perth, Australia. (AUD$30,000 in research costs)

 

2017                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Australasian Malignant PLeural Effusion (AMPLE) Trial-3: a multicentre randomized study comparing surgical pleurodesis vs indwelling pleural catheter for management of malignant pleural effusions

Lee YCG. (AUD$40,000)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2017                Project Grant, Cancer Council of Western Australia, Australia. 

  • The effect of FGF-9 on anti-tumour immunity in mesothelioma.

   Lansley SM, Lee YCG, Creaney J, Robinson BWS.  

   Institute for Respiratory Health, Perth, Australia.

 

2017                Western Australia Health Medical and Health Research Infrastructure Fund for 2016. 

Lee YCG. (AUD$57,931)                Institute for Respiratory Health, Perth, Australia.

 

2016                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • PLeural Effusion And Symptom Evaluation (PLEASE) Study:

   A comprehensive study of breathlessness in patients with a pleural effusion  

Lee YCG. (AUD$50,000)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2016                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Optimising antibiotic (piperacillin/tazobactam) therapy in pleural infection and cystic fibrosis

   using a newly developed antibiotic assay

   Popowicz N. (AUD$46,005)           Sir Charles Gairdner Hospital, Perth, Australia.

 

2016-18           Project Grant, NSW Workers' Compensation Dust Disease Board, Australia.

  • Phase II Trial of a Novel FGF-Receptor Antagonist in Mesothelioma.

   Lee YCG, Creaney J, Nowak A, Millward M and Musk AW.   (AUD$249,877)  

   Institute for Respiratory Health, Perth, Australia.

 

2016                Project Grant, Cancer Council of Western Australia, Australia. 

  • Australasian Malignant Pleural Effusion (AMPLE) Trial-2.

Lee YCG, Maskell N, Murray K, Creaney J, Newton R and Thomas R.   (AUD$100,000)  

University of Western Australia, Perth, Australia.

 

2016                Project Grant, Cancer Australia, Australia. 

  • Identification of the molecular networks that drive mesothelioma invasion.

Lesterhuis W, Bosco A, Lee YCG, Lake R and Lansley S.   (AUD$100,000)  

University of Western Australia, Perth, Australia.

 

2016                Slater & Gordon Travel Award, Thoracic Society of Australia & NZL. 

  • Lee YCG. (AUD$5,000)     University of Western Australia, Perth, Australia.

 

2016-2020       Centre of Research Excellence Grant, National Health & MRC, Australia.

  • National Centre for Asbestos Related Diseases.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, Lesterhuis W, Lee YCG, Francis R,

Holt R and Waddell N.   (AUD$2,495,164)   University of Western Australia, Perth, Australia.

 

2016                Western Australia Health Medical and Health Research Infrastructure Fund for 2015. 

Lee YCG. (AUD$50,614)               Lung Institute of Western Australia, Perth, Australia.

 

2015-16           Project Grant, NSW Workers' Compensation Dust Disease Board, Australia.

  • Establishing the biological activities of malignant effusions in malignant pleural mesothelioma.

   Creaney J and Lee YCG.   (AUD$239,432)   Institute for Respiratory Health, Perth, Australia.

 

2015-16           Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Australasian Malignant Pleural Effusion (AMPLE) Trial-2

   Lee YCG. (AUD$45,000)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2015-18           Project Grant, National Health & Medical Research Council, Australia. 

  • A randomised controlled trial of interventional versus conservative treatment of primary spontaneous pneumothorax.

   Brown S, Keijzers G, Smith J, Lee YCG. (AUD$401,143)

   University of Western Australia, Perth, Australia.

 

2015                Project Grant, Cancer Council of Western Australia, Australia. 

  • A comprehensive study of breathlessness in patients with a malignant pleural effusion.

   Lee YCG, Eastwood PR, Jenkins S, Singh B and Thomas R. (AUD$99,966)

   University of Western Australia, Perth, Australia.

 

2015                Western Australia Health Medical and Health Research Infrastructure Fund for 2014.  

Lee YCG. (AUD$46,266)               Lung Institute of Western Australia, Perth, Australia.

2014                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Australasian Malignant PLeural Effusion (AMPLE) Trial – a multi-national multi-centre

  randomised clinical trial

   Lee YCG. (AUD$39,626)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2014                Alan King Westcare Project Grant, Lung Institute of Western Australia, Australia. 

·  Translational research program in pleural infection

    Lee YCG. (AUD$50,000)              University of Western Australia, Perth, Australia.

 

2014                Project Grant, Cancer Council of Western Australia, Australia. 

  • Outcomes and predictors of efficacy of palliative radiotherapy in patients with malignant pleural mesothelioma.

   Nowak A, Francis R, Lee YCG, Bydder S, Creaney J. (AUD$99,679)

   University of Western Australia, Perth, Australia.

 

2013-2015       Project Grant, National Health & Medical Research Council, Australia. 

  • Therapeutic targeting of a new growth factor in mesothelioma.

   Lee YCG (PI) and Creaney J. (AUD$306,806)   University of Western Australia, Australia.

 

2013-16           Career Development Fellowship (Level II), NH&MRC, Australia.   

   Lee YCG (PI).   (AUD$307,944)    University of Western Australia, Perth, Australia.

 

2013                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Optimizing the use of indwelling pleural catheter in management of malignant pleural effusions

   Lee YCG. (AUD$50,000)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2012-14           Project Grant, NSW Workers' Compensation Dust Disease Board, Australia.

  • Fibroblast Growth Factor 9: a novel therapeutic and biomarker target in mesothelioma.

   Lee YCG (PI) and Creaney J.   (AUD$249,420)

   Lung Institute of Western Australia, Perth, Australia.

 

2012-14           Project Grant, NSW Workers' Compensation Dust Disease Board, Australia.

  • A multicentre randomised study comparing indwelling pleural catheter vs talc pleurodesis in

   patients with mesothelioma or other malignant pleural effusions.

   Fysh E, Lee YCG and Musk AW.   (AUD$246,168)

   Lung Institute of Western Australia, Perth, Australia.

 

2012                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Biological roles of malignant pleural fluid in the carcinogenesis of mesothelioma

   Lee YCG. (AUD$49,825)               Sir Charles Gairdner Hospital, Perth, Australia.

 

2012                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • A Phase 1, open label, non-randomised safety trial of intra-abdominal tPA and DNase in peritoneal

   dialysis patients with peritonitis

   Chakera A, Boudville N and Lee YCG. (AUD$42,690)   Sir Charles Gairdner Hospital, Australia.

 

2012                Project Grant, Cancer Council of Western Australia, Australia.  

  • A multicentre randomized study comparing indwelling pleural catheter v talc pleurodesis in patients with a malignant pleural effusion.

   Lee YCG (PI), Waterer GW, Musk AW and Millward M.   (AUD$61,807)

   University of Western Australia, Perth, Australia.

 

2012                Alan King Westcare Project Grant, Australia. 

  • Translational research in pleural infection to optimize antibiotics choice and improve pus drainage

   Lee YCG (PI), Kay I, Lansley S and Brown JS.   (AUD$50,000)

   Lung Institute of Western Australia, Perth, Australia.

 

2011    ACRF Cancer Imaging Facility grant, Australian Cancer Research Foundation, Australia.

  • Awarded for setting up of PET-MRI imaging facilities for preclinical models.

  Leedman P (PI), Ganss R, Lee YCG, Lake R, Sampson D, Klinken P, Saunders C, Lawrance I,    

  Kees U and Francis R. (AUD$2,400,000)   

  Western Australian Institute for Medical Research, Perth, Australia.

 

2011                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • Anti-tumour effects of Staphylococcal enterotoxin C in murine models of malignant mesothelioma.

   Lee YCG (PI) and S Lansley.   (AUD$29,740)      Sir Charles Gairdner Hospital, Perth, Australia.

 

2011                Project Grant, Cancer Council of Western Australia, Australia. 

  • Fibroblast Growth Factor (FGF)-9: A novel target in mesothelioma.

   Lee YCG (PI), Creaney J and Musk AW.   (AUD$90,000)

   University of Western Australia, Perth, Australia.

 

2010                Project Grant, Sir Charles Gairdner Research Advisory Committee, Australia. 

  • The Western Australian Malignant Pleural Effusion Management Study.

   Lee YCG (PI) and Fysh E.   (AUD$50,000)      Sir Charles Gairdner Hospital, Perth, Australia.

 

2010-11           Project Grant, Raine Medical Research Foundation, Australia. 

  • Antagonizing transforming growth factor-beta activity in the management of pleural infection.

   Lee YCG (PI), Waterer GW and Mutsaers SE.   (AUD$150,000)

   University of Western Australia, Perth, Australia.

 

2010                WestCare Project Grant on Infectious Lung Disease, Australia. 

  • Biological interactions of Streptococcal pneumoniae and pleural mesothelial cells in pleural infection.

   Lee YCG (PI) and Waterer GW. (AUD$50,000)     Lung Institute of Western Australia, Australia.

 

2009-2011       Project Grant, National Health & Medical Research Council, Australia. 

  • The role of the Hedgehog signaling pathway in asbestos associated malignant mesothelioma.

   Mutsaers SE (PI) and Lee YCG. (AUD$541,500)   University of Western Australia, Australia.

 

2009-2010       Mick Knighton Project Grant, British Lung Foundation, United Kingdom. 

  • Mesenchymal stem cells as therapeutic vectors for malignant pleural mesothelioma.

   Janes SM (PI) and Lee YCG.   (£100,000)

   University College London, U.K. and University of Western Australia, Perth, Australia.

 

2009-2010       Project Grant, State Health Research Advisory Council, Western Australia. 

  • Novel community-based care for malignant pleural effusions.

   Lee YCG (PI), Waterer GW, Kendell P, Geelhoed E.   (AUD$160,000)

   University of Western Australia, Perth, Australia.